Fenoterol hydrobromide NEW
| Price | $74 |
| Package | 1mL |
| Supply Ability: | 10g |
| Update Time: | 2026-06-02 |
Product Details
| Product Name: Fenoterol hydrobromide | CAS No.: 1944-12-3 |
| Purity: 99.88% | Supply Ability: 10g |
| Release date: 2026/06/02 |
Product Introduction
Bioactivity
| Name | Fenoterol hydrobromide |
| Description | Fenoterol hydrobromide is an orally active and selective β2-adrenoceptor agonist and bronchodilator used in the study of cardiovascular diseases such as asthma and bronchitis. |
| In vitro | Fenoterol hydrobromide inhibited lipopolysaccharide (LPS)-induced AMPK activation and inflammatory cytokine production in THP-1 cells. Fenoterol hydrobromide treatment reduced AICAR-induced AMPK activation, NF-κB activation and TNF-α release, and also significantly down-regulated the elevated phosphorylation level of AMPK. [1] Fenoterol hydrobromide is a potent activator of exosome biogenesis and/or secretion in PC cells. [2] |
| In vivo | 0.7 mg/kg Fenoterol hydrobromide injected intraperitoneally twice daily was treated to suppress mechanically abnormal pain during chronic treatment. [3] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 3.3 mg/mL (8.59 mM), Sonication is recommended. H2O : 20 mg/mL (52.05 mM), Sonication is recommended. 10% DMSO+90% Saline : 10 mg/mL (26.02 mM), Solution. DMSO : 150 mg/mL (390.35 mM), Sonication is recommended. |
| Keywords | β2-adrenoceptor | β2 adrenoreceptor | Fenoterol Hydrobromide | AdrenergicReceptor | Adrenergic Receptor |
| Inhibitors Related | Trifluoperazine dihydrochloride | Mirtazapine | Octopamine hydrochloride | Gemfibrozil | Buflomedil hydrochloride | Dexmedetomidine hydrochloride | Isoprenaline hydrochloride | D-Mannitol | Mianserin hydrochloride | Trazodone hydrochloride | Atenolol | Doxepin hydrochloride |
| Related Compound Libraries | Bioactive Compound Library | Neuronal Signaling Compound Library | Approved Drug Library | Membrane Protein-targeted Compound Library | ReFRAME Related Library | Drug-induced Liver Injury (DILI) Compound Library | Toxic Compound Library | Neurotransmitter Receptor Compound Library | Drug Repurposing Compound Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | GPCR Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
|
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-06-03 | ||
| $10.00 |
VIP4Y
|
Enki Biopharmaceuticals (Shanghai) Limited
|
2026-06-23 | |
|
VIP5Y
|
Sinoway Industrial co., ltd.
|
2026-06-22 | ||
| $1.10 |
VIP6Y
|
Dideu Industries Group Limited
|
2025-11-18 | |
| $2.00 |
VIP7Y
|
Career Henan Chemical Co
|
2020-01-09 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY